Result of NAT2
|
External Database Link |
|
|
External Database Link |
UniGene, LocusLink, OMIM, Ensembl, Genome Browser, MGC, SNP |
| Gene Information | |||||||||||||||||||||||||||
| Official Gene Symbol | NAT2 | ||||||||||||||||||||||||||
| Official Gene Name | N-acetyltransferase 2 (arylamine N-acetyltransferase) | ||||||||||||||||||||||||||
| Aliases |
Arylamine N-acetyltransferase-2 arylamide acetylase 2 (N-acetyltransferase 2, isoniazid inactivation) |
||||||||||||||||||||||||||
| LocusLink Summary |
The intronless NAT2 gene encodes N-acetyltransferase 2 (arylamine N-acetyltransferase 2). This enzyme functions to both activate and deactivate arylamine and hydrazine drugs and carcinogens. Polymorphisms in this gene are reponsible for the N-acetylation polymorphism in which human populations segregate into rapid,intermediate, and slow acetylator phenotypes. Polymorphisms in NAT2 are also associated with higher incidences of cancer and drug toxicity.A second arylamine N-acetyltransferase gene (NAT1) is located near NAT2. |
||||||||||||||||||||||||||
| GeneRIF:
Gene References into Function: |
|
||||||||||||||||||||||||||
| RefSeq | NM_000015 ( Reviewed ) | ||||||||||||||||||||||||||
| Gene Ontology |
|
||||||||||||||||||||||||||
| SwissProt Information | |||||||||||||||||||||||||||
| SwissProt ID/Primary Accession Number | ARY2_HUMAN / P11245 | ||||||||||||||||||||||||||
| Description | Arylamine N-acetyltransferase 2 (EC 2.3.1.5) (Arylamide acetylase 2) | ||||||||||||||||||||||||||
| Comments |
|
||||||||||||||||||||||||||
| SNP Information | |||||||||||||||||||||||||||
| Source | NAT2 | ||||||||||||||||||||||||||
| Created on | 10/27/2003 18:11:44 | ||||||||||||||||||||||||||
| SNPs | 84 (avg dist: 312) [View all 84 SNPs...] | ||||||||||||||||||||||||||
กก
กก